Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + Radiation for Brain Metastases
NCT00033254Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2002
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in brain metastases, sponsored by National Cancer Institute. Started Mar 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00033254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033254.